|
|
-
|
-
|
|
|
|
|
-
|
-
|
|
|
|
|
-
|
-
|
Carc. 1B; Acute Tox. 3; Skin Sens. 1
|
|
|
|
-
|
-
|
Acute Tox. 2; Acute Tox. 1
|
|
|
|
-
|
-
|
Acute Tox. 2; Acute Tox. 1
|
|
|
|
-
|
-
|
|
|
|
|
-
|
-
|
Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2
|
|
|
|
-
|
-
|
Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
|
|
|
|
-
|
-
|
Acute Tox. 2; Acute Tox. 1
|
|
|
|
-
|
-
|
|
|
|
|
-
|
-
|
|
|
|
|
-
|
-
|
|
|
|
|
-
|
-
|
Unst. Expl.; Acute Tox. 3
|
|
|
|
-
|
-
|
|
|
|
|
-
|
-
|
|
|
|
|
-
|
-
|
|
|
|
|
-
|
-
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
|
|
-
|
-
|
|
|
|
|
-
|
-
|
|
|
|
|
-
|
-
|
|
|
|
|
-
|
-
|
|
|
|
|
-
|
-
|
|
|
|
|
-
|
-
|
|
|
|
|
-
|
-
|
|
|
|
|
-
|
-
|
|
|
|
|
205-801-0
|
152-16-9
|
Acute Tox. 1; Acute Tox. 2
|
|
|
|
203-300-1
|
105-46-4
|
|
|
|
|
213-104-8
|
924-43-6
|
Flam. Liq. 2; Acute Tox. 4
|
|
|
|
611-802-0
|
591-34-4
|
|
|
|
|
237-732-7
|
13952-84-6
|
Flam. Liq. 2; Acute Tox. 4; Skin Corr. 1A
|
|
|
|
247-554-1
|
26259-45-0
|
Acute Tox. 4; Eye Irrit. 2
|
|
|
|
231-957-4
|
7782-49-2
|
|
|
Residues, zinc refining flue dust wastewater, mercury-selenium
The hot gases obtained by the roasting of raw zinc concentrate are cooled and cleaned from dust by passing through a spray of dilute sulfuric acid and/or water. This acid and/or water is filtered; the solid residue contains most of the volatile components of the concentrates to be roasted.
EC / List no:
309-609-9
| CAS no:
100403-63-2
Selenourea
EC / List no:
211-129-9
| CAS no:
630-10-4
Selenium
EC / List no:
231-957-4
| CAS no:
7782-49-2
|
-
|
-
|
|
|
|
|
-
|
-
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
|
|
-
|
-
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
|
|
-
|
-
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
|
|
-
|
-
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
B Bacteria and similar species
|
|
|
272-697-1
|
68909-20-6
|
|
|
|
|
-
|
68130-19-8
|
Carc. 1A; Repr. 1A; STOT RE 1; Skin Sens. 1
|
|
|
|
253-461-7
|
37321-15-6
|
Carc. 1A; STOT RE 1; Skin Sens. 1
|
|
|
|
206-991-8
|
409-21-2
|
|
|
|
|
-
|
308076-74-6
|
|
|
|
|
233-054-0
|
10026-04-7
|
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
|
|
|
|
605-752-9
|
175217-20-6
|
|
|
|
|
603-404-0
|
130328-20-0
|
Repr. 2; Skin Irrit. 2; Eye Dam. 1
|
|
|
|
|
|
|
